SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-017845
Filing Date
2020-09-15
Accepted
2020-09-15 16:45:27
Documents
16
Period of Report
2020-09-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44425
2 ex99-1.htm EX-99.1 20834
3 ex99-2.htm EX-99.2 14413
4 ex99-1_001.jpg GRAPHIC 3282
5 ex99-2_001.jpg GRAPHIC 6666
  Complete submission text file 0001493152-20-017845.txt   285626

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mtnb-20200911.xsd EX-101.SCH 3210
7 XBRL LABEL FILE mtnb-20200911_lab.xml EX-101.LAB 35273
8 XBRL PRESENTATION FILE mtnb-20200911_pre.xml EX-101.PRE 23162
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3770
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 201176444
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences